Mechanistic insights into flavonoid-mediated regulation of human influenza virus replication.

Authors

Dibakar Chowdhury, Hillary A Vanderven, Phurpa Wangchuk, Subir Sarker

Published in

Virology. Volume 623. Pages 111012. Jun 17, 2026. Epub Jun 17, 2026.

Abstract

Influenza A virus (IAV) remains a major global health concern due to its rapid mutation rate, antigenic variability, and the emergence of resistance to frontline antivirals such as oseltamivir and zanamivir. Despite available vaccines and therapeutics, their limited efficacy against emerging strains underscores the urgent need for new antiviral approaches. Therefore, plant-derived bioactive compounds, particularly flavonoids, have gained attention for their ability to target both viral and host pathways, yet their mechanisms of action remain incompletely understood. This review synthesises current evidence on the antiviral potential of plant-derived flavonoid against human IAV subtypes H1N1 and H3N2. Flavonoids disrupt key stages of the viral life cycle, including attachment, entry and release, and interact with IAV proteins such as hemagglutinin (HA), neuraminidase (NA), nucleoprotein (NP), and matrix-2 (M2) ion channels. The ability of plant-derived compounds to inhibit viral replication underscores their potential as leads for next-generation influenza therapeutics. Nonetheless, rigorous in vivo studies, mechanistic elucidation, and pharmacokinetic evaluations are essential to advance these candidates toward clinical translation.

PMID:
42320111
Bibliographic data and abstract were imported from PubMed on 20 Jun 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.